Researchcancerimmunotherapy.com

Visit researchcancerimmunotherapy.com
  • 7 months ago

    Last scanned

  • 10 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Researchcancerimmunotherapy.com

Visit researchcancerimmunotherapy.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Roche - Doing now what patients need next

As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

Researchcancerimmunotherapy.com thumbnail
Researchcancerimmunotherapy.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Hoffmann LaRoche, Inc., which reserves the following IP addresses for researchcancerimmunotherapy.com: 198.21.19.135. Moreover, DNS used with this website include a1-178.akam.net, a18-66.akam.net, a4-67.akam.net, a6-65.akam.net, a7-66.akam.net, a9-66.akam.net. Subnet identifier ranges from 198.21.16.0 to 198.21.31.255. Classless Inter-Domain Routing (CIDR) is 198.21.16.0/20. ARIN net type is Direct Allocation.

  • 7 months ago

    Last scanned

  • 10 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of researchcancerimmunotherapy.com is Safenames Ltd. and the name expires on 2024-05-28. According to open source data, you can reach the owner at hostmaster@safenames.net but please make sure you have a good reason for unsolicited messages. Their country of residence is UK.

  • science
  • research
  • Healthcare
  • medicines
  • patients
  • innovation
  • Pharma
  • LifeScience
  • diagnostics tests
  • cancer immunity cycle

Websites similar to researchcancerimmunotherapy.com